Related Experiment Video
Updated: Jun 28, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
[Arterial hypertension in pregnancy]
1Service de Médecine Interne et Clinique d'Hypertension Artérielle, Hôpital Erasme, Bruxelles. marc.leeman@ulb.ac.be
Revue Medicale De Bruxelles
|October 28, 2008
Summary
Managing hypertensive disorders in pregnancy is crucial for maternal and infant health. Key strategies include monitoring for organ damage, careful medication selection, and timely delivery when necessary.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Nephrology
Context:
- Hypertensive disorders are the most frequent medical complications during pregnancy.
- These conditions are linked to negative maternal and perinatal results.
- Chronic hypertension in pregnancy requires screening for target organ damage, particularly renal issues.
Purpose:
- To provide guidance on the management of hypertensive disorders in pregnancy.
- To highlight safe antihypertensive medications and those to avoid.
- To outline strategies for detecting and managing superimposed preeclampsia and eclampsia.
Summary:
- Blood pressure in pregnancy typically declines mid-gestation and rises in the third trimester, allowing potential withdrawal and reintroduction of antihypertensive therapy in low-risk cases.
- Labetalol, methyldopa, and nifedipine are recommended antihypertensives; ACE inhibitors, ARBs, and atenolol should be avoided.
- Preeclampsia detection involves clinical and lab evaluation. Low-dose aspirin and calcium may reduce risk. Expectant management for early-onset preeclampsia requires close monitoring. Intravenous labetalol and oral nifedipine are recommended for severe hypertension. Delivery is indicated for maternal/fetal distress. Magnesium sulfate is used for eclampsia prophylaxis and treatment.
- Most antihypertensives are safe during breastfeeding. Early-onset or severe preeclampsia is associated with increased long-term risks of chronic hypertension and cardiovascular disease.
Impact:
- Informs clinical practice for managing pregnant patients with hypertension.
- Aims to improve maternal and perinatal outcomes by guiding treatment decisions.
- Highlights the importance of long-term cardiovascular health monitoring post-preeclampsia.
Related Concept Videos
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...